Causal effects of circulating cytokine concentrations on risk of Alzheimer?s disease and cognitive function

被引:34
作者
Pagoni, Panagiota [1 ,2 ,3 ]
Korologou-Linden, Roxanna S. [1 ,2 ]
Howe, Laura D. [1 ,2 ]
Smith, George Davey [1 ,2 ]
Ben-Shlomo, Yoav [2 ]
Stergiakouli, Evie [1 ,2 ]
Anderson, Emma L. [1 ,2 ]
机构
[1] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Gloucestershire, England
[2] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Gloucestershire, England
[3] MRC Integrat Epidemiol Unit, Oakfield House,Oakfield Grove, Bristol BS8 2BN, Gloucestershire, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
Neuroinflammation; Cytokines; Alzheimer?s disease; Cognitive function; Mendelian randomization; MENDELIAN RANDOMIZATION; CEREBROSPINAL-FLUID; GENETIC-VARIANTS; INSTRUMENTS; INFLAMMATION; PATHOGENESIS; ASTROCYTES; EXPRESSION; BIAS;
D O I
10.1016/j.bbi.2022.05.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: There is considerable evidence suggesting a role of neuroinflammation in the pathogenesis of Alzheimer's disease. Establishing causality is challenging due to bias from reverse causation and residual confounding.Methods: We used two-sample MR to explore causal effects of circulating cytokine concentrations on Alzheimer's disease risk and cognitive function. We employed genetic variants from the largest publicly available genomewide association studies (GWASs) of cytokine concentrations (N = 8,293), Alzheimer's disease (71,880 cases/ 383,378 controls), prospective memory (N = 152,605 to 462,302), reaction time (N = 454,157 to 459,523) and fluid intelligence (N = 149,051).Results: Evidence suggest that 1 standard deviation (SD) increase in levels of CTACK (CCL27) (OR = 1.09 95%CI: 1.01 to 1.19, p = 0.03) increased risk of Alzheimer's disease. There was weak evidence of a causal effect of MIP1b (CCL4) (OR = 1.04 95% CI: 0.99 to 1.09, p = 0.08), Eotaxin (OR = 1.08 95% CI: 0.99 to 1.17, p = 0.10), GROa (CXCL1) (OR = 1.04 95% CI: 0.99 to 1.10, p = 0.15), MIG (CXCL9) (OR = 1.17 95% CI: 0.97 to 1.41, p = 0.10), IL-8 (Wald ratio: OR = 1.21 95% CI: 0.97 to 1.51, p = 0.09) and IL-2 (Wald Ratio: OR = 1.21 95% CI: 0.94 to 1.56, p = 0.14) on Alzheimer's disease risk. A 1 SD increase in concentration of Eotaxin (IVW: OR = 1.05 95% CI: 0.98 to 1.13, p = 0.14), IL-8 (OR = 1.21 95% CI: 1.07 to 1.37, p = 0.003) and MCP1 (OR = 1.07 95% CI: 1.03 to 1.13, p = 0.003) were associated with lower fluid intelligence, and IL-4 (OR = 0.86 95%CI: 0.79 to 0.98, p = 0.02) with higher.Conclusions: Our findings suggest a causal role of cytokines in the pathogenesis of Alzheimer's disease and fluid intelligence.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 57 条
[41]   Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies [J].
Shen, Xue-Ning ;
Niu, Li-Dong ;
Wang, Yan-Jiang ;
Cao, Xi-Peng ;
Liu, Qiang ;
Tan, Lan ;
Zhang, Can ;
Yu, Jin-Tai .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (05) :590-598
[42]   What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? [J].
Smith, GD ;
Ebrahim, S .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7499) :1076-1079
[43]   Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease [J].
Soares, Holly D. ;
Potter, William Z. ;
Pickering, Eve ;
Kuhn, Max ;
Immermann, Frederick W. ;
Shera, David M. ;
Ferm, Mats ;
Dean, Robert A. ;
Simon, Adam J. ;
Swenson, Frank ;
Siuciak, Judith A. ;
Kaplow, June ;
Thambisetty, Madhav ;
Zagouras, Panayiotis ;
Koroshetz, Walter J. ;
Wan, Hong I. ;
Trojanowski, John Q. ;
Shaw, Leslie M. .
ARCHIVES OF NEUROLOGY, 2012, 69 (10) :1310-1317
[44]   Microglia function in Alzheimer's disease [J].
Solito, Egle ;
Sastre, Magdalena .
FRONTIERS IN PHARMACOLOGY, 2012, 3
[45]   Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP_1, CXCL10, and viral RNA in the lungs of rhesus Macaques [J].
Sui, YJ ;
Li, SP ;
Pinson, D ;
Adany, I ;
Li, Z ;
Villinger, F ;
Narayan, O ;
Buch, S .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :355-365
[46]   Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline [J].
Taipa, Ricardo ;
das Neves, Sofia P. ;
Sousa, Ana L. ;
Fernandes, Joana ;
Pinto, Claudia ;
Correia, Ana P. ;
Santos, Ernestina ;
Pinto, Pedro S. ;
Carneiro, Paula ;
Costa, Patricio ;
Santos, Diana ;
Alonso, Isabel ;
Patna, Joana ;
Marques, Fernanda ;
Cavaco, Sara ;
Sousa, Nuno .
NEUROBIOLOGY OF AGING, 2019, 76 :125-132
[47]   Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly [J].
Tejera, Dario ;
Heneka, Michael T. .
CURRENT ALZHEIMER RESEARCH, 2016, 13 (04) :370-380
[48]  
Tsui Alex, 2018, Aging Med (Milton), V1, P249, DOI 10.1002/agm2.12046
[49]   The role of inflammation in Alzheimer's disease [J].
Tuppo, EE ;
Arias, HR .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (02) :289-305
[50]   CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease [J].
Westin, Karin ;
Buchhave, Peder ;
Nielsen, Henrietta ;
Minthon, Lennart ;
Janciauskiene, Sabina ;
Hansson, Oskar .
PLOS ONE, 2012, 7 (01)